468065-21-6Relevant articles and documents
APROSAMINE DERIVATIVES
-
Page/Page column 53-56, (2022/02/05)
The present disclosure provides compounds for the treatment of medical disorders caused by bacteria, in particular aprosamine derivatives for the treatment of bacterial infections.
Conjugated antimicrobial agents
-
Page/Page column 34; 38, (2015/10/28)
Provided herein are antimicrobial conjugates of two antibiotic agents, exhibiting improved activity also against resistant bacteria, compared to each of the agents separately or their mixture, and having substantially no resistance emerged thereagainst, as well as processes for preparation the same, compositions containing the same, and uses thereof in medical treatments against pathogenic microorganisms. The disclosed antimicrobial conjugates are composed of aminoglycosides and non-ribosomal active antibiotics. Some of the antimicrobial conjugates are prepared via “click” chemistry.
Design, synthesis, and evaluation of novel fluoroquinolone - Aminoglycoside hybrid antibiotics
Pokrovskaya, Varvara,Belakhov, Valery,Hainrichson, Mariana,Yaron, Sima,Baasov, Timor
scheme or table, p. 2243 - 2254 (2010/02/28)
A series of new hybrid structures containing fluoroquinolone (ciprofloxacin) and aminoglycoside (neomycin) antibiotics linked via 1,2,3-triazole moiety were designed and synthesized, and their antibacterial activities were determined against both Gram-neg